Matches in Nanopublications for { ?s ?p "[The polymorphism in intron 4 of endothelial nitric oxide synthase altered endothelial response to folate significantly: in subjects with diabetes FMD improved by 6.4 ? 5% (insertion carriers) vs 2.3 ? 6.6% (deletion carriers), P = .01; in obese subjects FMD improved by 1.8 ? 5.4% (insertion carriers) and deteriorated by -3.2 ? 7.2% (deletion carriers), P = .05.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[The polymorphism in intron 4 of endothelial nitric oxide synthase altered endothelial response to folate significantly: in subjects with diabetes FMD improved by 6.4 ? 5% (insertion carriers) vs 2.3 ? 6.6% (deletion carriers), P = .01; in obese subjects FMD improved by 1.8 ? 5.4% (insertion carriers) and deteriorated by -3.2 ? 7.2% (deletion carriers), P = .05.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The polymorphism in intron 4 of endothelial nitric oxide synthase altered endothelial response to folate significantly: in subjects with diabetes FMD improved by 6.4 ? 5% (insertion carriers) vs 2.3 ? 6.6% (deletion carriers), P = .01; in obese subjects FMD improved by 1.8 ? 5.4% (insertion carriers) and deteriorated by -3.2 ? 7.2% (deletion carriers), P = .05.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The polymorphism in intron 4 of endothelial nitric oxide synthase altered endothelial response to folate significantly: in subjects with diabetes FMD improved by 6.4 ? 5% (insertion carriers) vs 2.3 ? 6.6% (deletion carriers), P = .01; in obese subjects FMD improved by 1.8 ? 5.4% (insertion carriers) and deteriorated by -3.2 ? 7.2% (deletion carriers), P = .05.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The polymorphism in intron 4 of endothelial nitric oxide synthase altered endothelial response to folate significantly: in subjects with diabetes FMD improved by 6.4 ? 5% (insertion carriers) vs 2.3 ? 6.6% (deletion carriers), P = .01; in obese subjects FMD improved by 1.8 ? 5.4% (insertion carriers) and deteriorated by -3.2 ? 7.2% (deletion carriers), P = .05.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The polymorphism in intron 4 of endothelial nitric oxide synthase altered endothelial response to folate significantly: in subjects with diabetes FMD improved by 6.4 ? 5% (insertion carriers) vs 2.3 ? 6.6% (deletion carriers), P = .01; in obese subjects FMD improved by 1.8 ? 5.4% (insertion carriers) and deteriorated by -3.2 ? 7.2% (deletion carriers), P = .05.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The polymorphism in intron 4 of endothelial nitric oxide synthase altered endothelial response to folate significantly: in subjects with diabetes FMD improved by 6.4 ? 5% (insertion carriers) vs 2.3 ? 6.6% (deletion carriers), P = .01; in obese subjects FMD improved by 1.8 ? 5.4% (insertion carriers) and deteriorated by -3.2 ? 7.2% (deletion carriers), P = .05.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.